All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

236

Reset

236 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • SHR-2173Phase 25 trials

    Guangdong Hengrui Pharmaceutical Co., Ltd · Generalized Myasthenia Gravis, Active Lupus Nephritis, Primary IgA Nephropathy

  • zamtocabtagene autoleucelMB-CART2019.1Phase 25 trials

    Miltenyi Biomedicine GmbH · CAR T Cell Therapy, Mantle Cell Lymphoma (MCL), Multiple Sclerosis

  • Descartes-08Phase 24 trials

    Cartesian Therapeutics · Myasthenia Gravis, Generalized, Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV)

  • EVO756Phase 24 trials

    Evommune, Inc. · Migraine, Chronic Inducible Urticaria, Atopic Dermatitis

  • ML-007C-MAPhase 24 trials

    MapLight Therapeutics · Psychosis Associated With Alzheimer's Disease, Schizophrenia

  • SevasemtenPhase 24 trials

    Edgewise Therapeutics, Inc. · Becker Muscular Dystrophy, Duchenne Muscular Dystrophy

  • SPN-817BIS-001ER, Huperzine APhase 24 trials

    Supernus Pharmaceuticals, Inc. · Focal Onset Seizures, Focal Impaired Awareness Seizures, Epilepsy

  • Ever Supreme Bio Technology Co., Ltd. · COVID-19 Infection, Multiple Sclerosis, ST Elevation Myocardial Infarction

  • BrogidirsenNS-089, NCNP-02Phase 23 trials

    NS Pharma, Inc. · Duchenne Muscular Dystrophy, Exon 44, DMD

  • Human Dopaminergic Progenitor CellsNouvNeu001Phase 23 trials

    iRegene Therapeutics Co., Ltd. · Parkinson Disease, Parkinson Disease (PD)

  • iPSChuman allogeneic induced pluripotent stem cell -derived dopaminergic neural progenitor cell, Allogeneic Human Induced Pluripotent Stem Cell -Derived Motor Neuron Progenitor CellsPhase 23 trials

    XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. · Spinal Cord Injury, Safety, Efficacy

  • LY4065967Phase 23 trials

    Eli Lilly · Chronic Pain, Diabetic Peripheral Neuropathic Pain, Osteoarthritis, Knee

  • NMD670Phase 23 trials

    NMD Pharma A/S · Myasthenia Gravis, Myasthenia Gravis, MuSK, Charcot-Marie-Tooth Disease

  • Zugocabtagene geleucelCTX112Phase 23 trials

    CRISPR Therapeutics AG · B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy

  • [18F]F-AraGPET tracer, 2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguaninePhase 22 trials

    CellSight Technologies, Inc. · Alzheimer Disease (AD), Covid19, SARS-CoV Infection

  • AB-1005Phase 22 trials

    AskBio Inc · PARKINSON DISEASE (Disorder), Parkinson Disease

  • ALT001Phase 22 trials

    Darwin Origin (Hubei) Biopharmaceutical Co., Ltd. · Ischemic Stroke in the Sequelae Stage, Amyotrophic Lateral Sclerosis (ALS)

  • AMDX-2011PPhase 22 trials

    Amydis Inc. · Cerebral Amyloid Angiopathy, Alzheimer Disease

  • Autologous HB-adMSCsPhase 22 trials

    Hope Biosciences LLC · Traumatic Brain Injury, Relapsing Remitting Multiple Sclerosis (RRMS), Multiple Sclerosis

  • BMB-101Phase 22 trials

    Bright Minds Biosciences Pty Ltd · Absence Epilepsy, Jeavons Syndrome, Dravet Syndrome

  • BMN 351Phase 22 trials

    BioMarin · Duchenne Muscular Dystrophy (DMD), Duchenne Muscular Dystrophy

  • BMS-986368CC-97489Phase 22 trials

    Bristol Myers Squibb · Agitation, Alzheimer Disease, Multiple Sclerosis Spasticity

  • C-CAR168Phase 22 trials

    AbelZeta Inc. · Lupus Nephritis (LN), Systemic Lupus Erythematosus (SLE), Autoimmune Diseases

  • CNMAu8gold nanocrystalsPhase 22 trials

    Clene Nanomedicine · Amyotrophic Lateral Sclerosis, Multiple Sclerosis

  • CT1812Study Drug ActivePhase 22 trials

    Cognition Therapeutics · Early Alzheimer's Disease, Dementia With Lewy Bodies

  • DNL151BIIB122Phase 22 trials

    Denali Therapeutics Inc. · Parkinson Disease

  • ENTR-601-44Phase 22 trials

    Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)

  • ENTR-601-45Phase 22 trials

    Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)

  • Foralumab NasalPhase 22 trials

    Tiziana Life Sciences LTD · ALS (Amyotrophic Lateral Sclerosis), ALS - Amyotrophic Lateral Sclerosis, ALS

  • GV101Phase 22 trials

    Graviton Bioscience Corporation · Friedreich's Ataxia, Weight Management

  • HBI-002Phase 22 trials

    Hillhurst Biopharmaceuticals, Inc. · Parkinson Disease, Anemia, Sickle Cell

  • KDS2010Phase 22 trials

    NeuroBiogen Co., Ltd · Overweight, Obesity, Obese Patients

  • matched to VX-993Phase 22 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain

  • mivelsiranALN-APPPhase 22 trials

    Alnylam Pharmaceuticals · Cerebral Amyloid Angiopathy, Down Syndrome-Associated Alzheimer's Disease (DS-AD)

  • NE3107bezisterimPhase 22 trials

    BioVie Inc. · Long COVID, Parkinsons Disease (PD)

  • ONO-2020Phase 22 trials

    Ono Pharmaceutical Co., Ltd. · Agitation Associated With Alzheimer's Disease Dementia, Alzheimer Disease

  • ORX750Phase 22 trials

    Centessa Pharmaceuticals (UK) Limited · Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia

  • RO7568282Phase 22 trials

    Roche (Genentech) · Parkinson's Disease, Alzheimer's Disease

  • SAT-3247Phase 22 trials

    Satellos Bioscience, Inc. · Duchenne Muscular Dystrophy, Duchenne, DMD

  • SNK01Phase 22 trials

    NKGen Biotech, Inc. · Alzheimer Disease, Moderate Alzheimer Disease

  • VHB937Phase 22 trials

    Novartis · Amyotrophic Lateral Sclerosis (ALS), Alzheimer's Disease

  • VIM0423Phase 22 trials

    Vima Therapeutics · PARKINSON DISEASE (Disorder), Dystonia

  • VTX3232Phase 22 trials

    Zomagen Biosciences Ltd. · Idiopathic Parkinson Disease, Obesity

  • VutiglabridinHSG4112Phase 22 trials

    Glaceum · Knee Osteoarthritis (Knee OA), Parkinson Disease

  • VX-993Phase 22 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain

  • WVE-N531Phase 22 trials

    Wave Life Sciences USA, Inc. · Duchenne Muscular Dystrophy

  • ABBV-1758Phase 21 trial

    AbbVie · Alzheimer's Disease

  • ABBV-916Phase 21 trial

    AbbVie · Alzheimer's Disease (AD)

  • ABS-1230Phase 21 trial

    Actio Biosciences, Inc. · KCNT1-Related Epilepsy

  • ALZN002autologous DCs pulsed with E22W mutant peptidePhase 21 trial

    Alzamend Neuro, Inc. · Alzheimer Disease

NewerPage 3 of 5Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.